This book is the first title that focuses exclusively on kidney disease and its impact in the cardiac catheterization laboratory. The increasing prevalence of vascular risk factors such as diabetes, obesity and hypertension coupled with increased longevity has resulted in a worldwide epidemic of cardiovascular and chronic kidney disease (CKD). Never has the impact of one organ system on the other been so profound, as in the current context of cardio-renal interactions. The cross talk between the heart and kidneys is highly relevant in the field of interventional cardiology, given the…mehr
This book is the first title that focuses exclusively on kidney disease and its impact in the cardiac catheterization laboratory. The increasing prevalence of vascular risk factors such as diabetes, obesity and hypertension coupled with increased longevity has resulted in a worldwide epidemic of cardiovascular and chronic kidney disease (CKD). Never has the impact of one organ system on the other been so profound, as in the current context of cardio-renal interactions. The cross talk between the heart and kidneys is highly relevant in the field of interventional cardiology, given the increasing number of trans-catheter procedures being performed in patients with underlying kidney disease. These procedures also have a significant impact on kidney function and require thoughtful interdisciplinary planning by a cardiorenal team, to achieve optimal outcomes
This book assembles the collective expertise of several international leaders in the field of interventional cardiology and nephrology to summarize this complex interface. The book is divided into seven sections to comprehensively cover the topic, including sections on best practices with reduction of contrast associated acute kidney injury, cutting edge techniques to minimize kidney risk with complex interventions, impact of transcatheter valvular procedures on kidney function and the utility of cardio-nephrology teams . Less recognized complications with high morbidity such as athero-embolic renal disease are featured prominently, to increase awareness in the interventional cardiology and nephrology communities.
This book is a valuable resource for interventional and structural cardiologists, general cardiologists and nephrologists dealing with the significant overlap areas between these two specialties. It is also relevant to medical students, trainee physicians in nephrology and cardiology, advanced care practitioners and nursing personnel in both specialties . Given the major impact of kidney function on outcomes in patients undergoing cardiac procedures, this textbook serves as a focal point to integrate relevant clinical data from both specialties and help interventional cardiologists achieve optimal outcomes, especially in patients with (or at risk for) kidney disease.
Janani Rangaswami, MD Clinical Associate Professor Einstein Medical Center / Thomas Jefferson University Department of Medicine / Nephrology Philadelphia, PA, USA Edgar V. Lerma, MD Clinical Professor of Medicine UIC/Advocate Christ Medical Center Department of Medicine Oak Lawn, IL, USA Peter A. McCullough, MD, MPH Consultant Cardiologists and Vice Chief of Internal Medicine Baylor University Medical Center Baylor Heart and Vascular Hospital Department of Internal Medicine Texas A & M College of Medicine Division of Cardiology Dallas, TX, USA
Inhaltsangabe
Section 1: Atherosclerotic Cardiovascular Disease Burden in Chronic Kidney Disease Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical OutcomesNoninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future DirectionsPeripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional StrategiesCardiovascular impact of Atherosclerotic Renovascular Disease Section 2: Therapeutic Considerations with revascularization in Chronic Kidney Disease Platelet Function testing and antiplatelet agent choice in CKDChoice of stents and clinical outcomes in patients with CKDRevascularization strategies in CKD: PCI vs CABGApproach to revascularization in the potential kidney transplant recipientNephrology consultative approach and risk stratification prior to revascularization in CKD Section 3: Acute Kidney Injury in the catheterization laboratory: Part I Contrast Induced AKI: Epidemiology, risk stratification and prognosisContrast induced AKI: Pathophysiological Mechanisms.Prevention of Contrast Induced AKI: Summary of volume optimization strategiesPrevention of Contrast induced AKI: Contrast medium selection, adjuvant strategies and best clinical practicesIntra procedural and operator strategies for reduction of contrast induced AKI Section 4: Acute Kidney Injury in the catheterization laboratory: Part II Effect of Percutaneous Ventricular Assist Devices on Renal FunctionRenal athero-embolic disease: An underdiagnosed entityAcute kidney injury with trans catheter aortic valve replacement Impact of kidney disease in catheter based mitral valve interventionsAcute kidney injury with peripheral vascular interventions Section 4: Catheter based Reno-vascular interventions Renal Artery Stenosis: State of the Art in Diagnosis and ManagementRenal Denervation: Physiology, scope and current evidence Section 5: Medical Economics of Kidney Disease in the Catheterization Laboratory Economic impact of AKI and CKD in cardiac interventionsBiomarkers in early risk stratification and management of post catheterization AKIUtilization of the cardio nephrology collaborative in the era of value based medicine
Section 1: Atherosclerotic Cardiovascular Disease Burden in Chronic Kidney Disease Coronary artery disease in CKD: Epidemiology, Pathophysiology and Clinical OutcomesNoninvasive testing in the diagnosis of ischemic heart disease in CKD: Scope, Pitfalls and Future DirectionsPeripheral Arterial Disease in CKD: Disease Burden, Outcomes and Interventional StrategiesCardiovascular impact of Atherosclerotic Renovascular Disease Section 2: Therapeutic Considerations with revascularization in Chronic Kidney Disease Platelet Function testing and antiplatelet agent choice in CKDChoice of stents and clinical outcomes in patients with CKDRevascularization strategies in CKD: PCI vs CABGApproach to revascularization in the potential kidney transplant recipientNephrology consultative approach and risk stratification prior to revascularization in CKD Section 3: Acute Kidney Injury in the catheterization laboratory: Part I Contrast Induced AKI: Epidemiology, risk stratification and prognosisContrast induced AKI: Pathophysiological Mechanisms.Prevention of Contrast Induced AKI: Summary of volume optimization strategiesPrevention of Contrast induced AKI: Contrast medium selection, adjuvant strategies and best clinical practicesIntra procedural and operator strategies for reduction of contrast induced AKI Section 4: Acute Kidney Injury in the catheterization laboratory: Part II Effect of Percutaneous Ventricular Assist Devices on Renal FunctionRenal athero-embolic disease: An underdiagnosed entityAcute kidney injury with trans catheter aortic valve replacement Impact of kidney disease in catheter based mitral valve interventionsAcute kidney injury with peripheral vascular interventions Section 4: Catheter based Reno-vascular interventions Renal Artery Stenosis: State of the Art in Diagnosis and ManagementRenal Denervation: Physiology, scope and current evidence Section 5: Medical Economics of Kidney Disease in the Catheterization Laboratory Economic impact of AKI and CKD in cardiac interventionsBiomarkers in early risk stratification and management of post catheterization AKIUtilization of the cardio nephrology collaborative in the era of value based medicine
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
